Senate Report Reveals Drug Companies Keep Increasing Prices Despite Trump Deal Commitments

The report uncovers that pharmaceutical companies have raised medication costs across hundreds of drugs while profits soared to $177 billion in 2025. This challenges the claimed effectiveness of Trump-era drug pricing agreements and suggests limited impact on consumer prices. Moving forward, congressional oversight and potential policy reforms are likely to intensify to address these discrepancies.